DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 07 · Volume 45 · November 2012 DOI: 10.1055/s-002-23975

Erratum

e2
Gahr, M.; Schmid, M. M.; Schönfeldt-Lecuona, C.: Pregabalin-associated Elevation of Clozapine Serum Levels

Review

261
Franz, M.; Ranger, J.; Hanewald, B.; Gallhofer, B.; Lay, B.: Influences on Therapist’s Decisions for Neuroleptic Treatment in Schizophrenia: The Role of Characteristics of the Patient and the Physician

Original Paper

269
Morgan, C.J. A.; Duffin, S.; Hunt, S.; Monaghan, L.; Mason, O.; Curran, H. V.: Neurocognitive Function and Schizophrenia-Proneness in Individuals Dependent on Ketamine, on High Potency Cannabis (‘Skunk’) or on Cocaine
275
Sarris, J.; Fava, M.; Schweitzer, I.; Mischoulon, D.: St John’s Wort (Hypericum perforatum) versus Sertraline and Placebo in Major Depressive Disorder: Continuation Data from a 26-Week RCT
279
Okayasu, H.; Ozeki, Y.; Fujii, K.; Takano, Y.; Saeki, Y.; Hori, H.; Horie, M.; Higuchi, T.; Kunugi, H.; Shimoda, K.: Pharmacotherapeutic Determinants for QTc Interval Prolongation in Japanese Patients with Mood Disorder
284
Laux, G.; and the VIVALDI Study Group: The Antidepressant Agomelatine in Daily Practice: Results of the Non-Interventional Study VIVALDI
292
Seemüller, F.; Lewitzka, U.; Bauer, M.; Meyer, S.; Musil, R.; Schennach, R.; Riedel, M.; Doucette, S.; Möller, H.-J.: The Relationship of Akathisia with Treatment Emergent Suicidality among Patients with First-Episode Schizophrenia Treated with Haloperidol or Risperidone

Letter

297
Gahr, M.; Schmid, M. M.; Schönfeldt-Lecuona, C.: Pregabalin-associated Elevation of Clozapine Serum Levels
299
Widschwendter, C. G.; Hofer, A.: Aripiprazole Use in Early Pregnancy: A Case Report